The experimental assessment consisted of direct measures of fibril disassembly (Fig. 2d, e and Supplementary Table 3) and assessment of the seeding capability of the products of disassembled AD tau fibrils in a biosensor cell assay25. The gene discussed is MAPT; the disease is Alzheimer disease.